By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of California, San Francisco, and Optivia Biotechnology today said that they have received a $430,000 Phase I Small Business Innovation Research grant to develop a system for characterizing the role transporter proteins play in the disposition of drugs by the liver.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.